Presentation: Half-year report for the six months ended 30 June 2023

Paul Pagano and David Anderson give a presentation on LungLife's Interim results for the six months ended 30 June 2023, via the Investor Meet Company platform.

Q&A with Lunglife AI's CEO, Paul Pagano

In this interview, Paul Pagano CEO of Lunglife AI #LLAI takes Vox through today’s ‘in line’ H1’23 results and the next steps wrt commercialising its ground-breaking early stage lung cancer blood test.

PRESENTATION: FULL YEAR RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022

Watch Paul Pagano and David Anderson give a presentation on LungLife's Annual Results for the year ended 31 December 2022, via the Investor Meet Company platform.

Presentation: Interim results for the six months ended 30 June 2022

Paul Pagano and David Anderson give a presentation on LungLife's Interim results for the six months ended 30 June 2022, via the Investor Meet Company platform.

Presentation: Full Year Results for the year ended 31 December 2021

Paul Pagano and David Anderson give a presentation on LungLife's Annual Results for the year ended 31 December 2021, via the Investor Meet Company platform.

Edison Open House interview with CEO, Paul Pagano

LungLife AI: Edison Open House Healthcare 2022

Half Year Results to 30 June, 2021

Paul Pagano and David Anderson talk with Justin Waite of VOX Markets.

Paul Pagano and David Anderson's presentation to the investor community on the results to the period.

Introduction to LungLife AI, Inc post Admission

Paul Pagano talks with Paul Hill of VOX Markets following the Company's IPO on 8 July, 2021.